BHE
Benchmark Electronics, Inc.
BHE's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over BHE overall, supported by stronger valuation and stronger fundamentals.
BHE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
BHE's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
BHE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $25.39 | -61% |
| Forward | 19x | $64.81 | — |
| Fair | 26x | $40.74 | -37% |
| Current | 42x | $64.81 | — |
| Expensive | 61x | $93.51 | +44% |
Historical ranges are pointers, not guarantees.
BHE's PE is in its expensive range at 42x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its cheap range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over BHE in the historical PE scenario, which offers more potential upside but is not a forecast.
BHE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
BHE has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
BHE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.41 | +121% |
| Q3 2026 | $1.54 | +52% |
| Q2 2026 | $1.46 | +40% |
| Q1 2026 | $0.94 | -35% |
| Q4 2025 | $0.68 | -60% |
| Q3 2025 | $1.01 | -41% |
| Q2 2025 | $1.04 | -44% |
| Q1 2025 | $1.44 | -21% |
| Q4 2024 | $1.72 | -3.9% |
BHE earned $1.54 per share over the past year, up 52% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over BHE on earnings, with more consistent year-over-year improvement.
BHE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $810.9M | +19% |
| Q2 2026 | $756M | +18% |
| Q1 2026 | $677.3M | +7.2% |
| Q4 2025 | $704.3M | +7.2% |
| Q3 2025 | $680.7M | +3.5% |
| Q2 2025 | $642.3M | -3.5% |
| Q1 2025 | $631.8M | -6.5% |
| Q4 2024 | $656.9M | -5% |
BHE's revenue has grown year over year for five quarters in a row: $811M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.8% | +0.3 points |
| Q2 2026 | 4% | +0.8 points |
| Q1 2026 | 3.2% | +1.4 points |
| Q4 2025 | 2.9% | -1.5 points |
| Q3 2025 | 3.5% | -0.8 points |
| Q2 2025 | 3.2% | -0.9 points |
| Q1 2025 | 1.9% | -1.9 points |
| Q4 2024 | 4.3% | -0.3 points |
BHE's operating margin was 3.8% last quarter, about level with the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over BHE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over BHE on profitability, with a higher operating margin.
BHE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $15.4M | -39% |
| Q2 2026 | $21.8M | +$36.9M |
| Q1 2026 | $31M | +10% |
| Q4 2025 | $48.2M | +30% |
| Q3 2025 | $25.1M | -14% |
| Q1 2025 | $28.1M | -35% |
| Q4 2024 | $37.2M | -71% |
| Q3 2024 | $29.2M | +63% |
BHE still generates free cash flow, though less than at its 2023 peak: $116M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over BHE on cash flow, with more consistent year-over-year improvement.
BHE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -1K shares |
| 1 year | +0.6% | +214K shares |
| 3 years | +1.4% | +520K shares |
| 5 years | +2% | +730K shares |
| Available history | -6.1% | -2.4M shares |
BHE has 36M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $8.5M |
| Q2 2026 | — |
| Q1 2026 | $5.8M |
| Q4 2025 | $854,000 |
| Q3 2025 | $10M |
| Q2 2025 | $8M |
| Q1 2025 | $8M |
| Q4 2024 | $1,000 |
BHE spent $15M buying back its own shares over the past year, down 42% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over BHE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
BHE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | -0.9x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.6x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
BHE has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BHE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.6 | Neutral |
| Stochastic | 14.1 | Oversold |
BHE's weekly RSI is 43 (neutral) and its Stochastic is 14 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
BHE PE vs Technology Sector
| Metric | BHE | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 28x | 51% above |
| PE % | 69 | 35 | 34 pts above |
BHE is trading at 42x earnings, a 51% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over BHE on valuation relative to its sector.
BHE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $72.7 | 11% below |
| 20 week MA | $76.3 | 15% below |
| 50 week MA | $68.7 | 5.7% below |
| 100 week MA | $54.4 | 19% above |
| 200 week MA | $43.0 | 51% above |
BHE has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
BHE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.6 | $26.7 | -23% |
| 2021 | $26.7 | $26.4 | -1% |
| 2022 | $26.4 | $27.0 | +2.2% |
| 2023 | $27.0 | $27.6 | +2.4% |
| 2024 | $27.6 | $46.1 | +67% |
| 2025 | $46.1 | $44.8 | -2.8% |
| 2026 YTD | $44.8 | $64.8 | +45% |
BHE has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.